BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jafarzadeh A, Paknahad MH, Nemati M, Jafarzadeh S, Mahjoubin-Tehran M, Rajabi A, Shojaie L, Mirzaei H. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. Biomed Pharmacother 2021;146:112600. [PMID: 34968919 DOI: 10.1016/j.biopha.2021.112600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chowdhury SG, Ray R, Karmakar P. Exosomal miRNAs-a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer. Funct Integr Genomics 2022;23:23. [PMID: 36574059 DOI: 10.1007/s10142-022-00951-8] [Reference Citation Analysis]
2 Matuszyk J. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Mol Med 2022;28:89. [PMID: 35922756 DOI: 10.1186/s10020-022-00516-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Erfanparast L, Taghizadieh M, Shekarchi AA. Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions. Front Oncol 2022;12:914593. [DOI: 10.3389/fonc.2022.914593] [Reference Citation Analysis]
4 Mirzaei H, Shahrzad M, Gharehgozlou R, Fadaei S, Hajian P. Association between serum Vitamin D levels and prognostic factors in nonmetastatic breast cancer patients. J Res Med Sci 2022;27:56. [DOI: 10.4103/jrms.jrms_951_21] [Reference Citation Analysis]
5 Asaturova A, Tregubova A, Magnaeva A. Molecular Subtypes of High-Grade Serous Ovarian Carcinoma. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_102] [Reference Citation Analysis]